Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels

被引:91
|
作者
Berrill, James W. [1 ]
Sadlier, Mike [2 ]
Hood, Kerenza [3 ]
Green, John T. [1 ]
机构
[1] Univ Hosp Llandough, Dept Gastroenterol, Cardiff CF64 2XX, S Glam, Wales
[2] Univ Wales Hosp, Dept Physiotherapy, Cardiff CF4 4XW, S Glam, Wales
[3] Cardiff Univ, South East Wales Trials Unit, Cardiff CF10 3AX, S Glam, Wales
关键词
Inflammatory bowel disease; Irritable bowel syndrome; Psychotherapy; Mindfulness; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; CROHNS-DISEASE; ULCERATIVE-COLITIS; CLINICAL-TRIALS; ACTIVITY INDEX; MANAGEMENT; HEALTH; IMPACT; PSYCHOTHERAPY;
D O I
10.1016/j.crohns.2014.01.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Psychological interventions are used in patients with inflammatory bowel disease (IBD) but there is uncertainty about who the optimal target population is. Multi-convergent therapy (MCT) is a form of psychotherapy that combines mindfulness meditation with aspects of cognitive behavioural therapy and has been used in the management of irritable bowel syndrome (IBS). This study aimed to assess the feasibility and efficacy of MCT in the management of IBD patients with either functional abdominal symptoms or high perceived stress levels. Methods: Sixty-six IBD patients in clinical remission with either IBS-type symptoms or high perceived stress levels were randomly allocated to a 16-week MCT course or waiting list control group. Patients were followed-up for one year with the Inflammatory Bowel Disease Questionnaire (IBDQ) as the primary outcome measurement. Results: A higher mean IBDQ score was observed in the active group compared to controls at the 4-month assessment (167 vs. 156, p = 0.081), but this was not statistically significant nor did it reached the predefined clinically significant difference of 20. In patients with IBS-type symptoms at baseline there was a significantly higher mean IBDQ score in the active group compared to controls (161 vs. 145, p = 0.021). There was no difference between groups in relapse rate based on faecal calprotectin measurement. Conclusions: IBS-type symptoms in patients with IBD represent a potential therapeutic target to improve quality of life. This study suggests that MCT may be useful in the management of these symptoms but larger studies are required to confirm this. (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:945 / 955
页数:11
相关论文
共 50 条
  • [31] The Efficacy of Mindfulness-Based Stress Reduction and Mindfulness-Based Cognitive Therapy on Cognitive Impairment in Post-Stroke Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Liu, Ying
    Yin, Shao
    Hu, Qian
    Fei, Youmei
    Zhong, Yue
    Ji, Qiang
    Zhu, Fengya
    MINDFULNESS, 2025, : 1116 - 1129
  • [32] Long-term treatment outcomes of mindfulness-based cognitive therapy for fatigue in patients with inflammatory bowel disease: Results of a randomized controlled trial
    Bredero, Quirine M.
    Fleer, Joke
    Smink, Ans
    Kuiken, Greetje
    Potjewijd, Joke
    Laroy, Marleen
    Visschedijk, Marijn C.
    Russel, Maurice
    van der Lugt, Mark
    Meijssen, Maarten A. C.
    van der Wouden, Egbert Jan
    Dijkstra, Gerard
    Schroevers, Maya J.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2024, 187
  • [33] Perspectives on an Acceptance and Commitment Therapy (ACT) based program for patients with inflammatory bowel disease and comorbid anxiety and/or depressive symptoms
    Dober, Madeleine
    Mikocka-Walus, Antonina
    Evans, Subhadra
    Beswick, Lauren
    Emerson, Catherine
    Olive, Lisa
    PSYCHOTHERAPY RESEARCH, 2021, 31 (05) : 668 - 681
  • [34] Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trial
    Kuelz, Anne Katrin
    Landmann, Sarah
    Cludius, Barbara
    Rose, Nina
    Heidenreich, Thomas
    Jelinek, Lena
    Alsleben, Heike
    Wahl, Karina
    Philipsen, Alexandra
    Voderholzer, Ulrich
    Maier, Jonathan G.
    Moritz, Steffen
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2019, 269 (02) : 223 - 233
  • [35] Venlafaxine as an Adjuvant Therapy for Inflammatory Bowel Disease Patients With Anxious and Depressive Symptoms: A Randomized Controlled Trial
    Liang, Chang
    Chen, Pingrun
    Tang, Yu
    Zhang, Chuheng
    Lei, Na
    Luo, Ying
    Duan, Shihao
    Zhang, Yan
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [36] Effects of Stress Reduction Therapy Based on Mindfulness-Based Stress Reduction (MBSR) on Emotion Regulation Strategies, Perceived Stress, And Quality of Life of Patients with Multiple Sclerosis
    Homayoon, Mohammadsadegh
    ASEAN JOURNAL OF PSYCHIATRY, 2022, 23 (04):
  • [37] Exploring Evidence for Mindfulness and Subjective Wellbeing Homeostatic Resilience Buffering Depression and Stress Symptoms Associated with Inflammatory Bowel Disease
    Lyall, Kimina
    Youssef, George
    Mikocka-Walus, Antonina
    Evans, Subhadra
    Cummins, Robert A.
    JOURNAL OF HAPPINESS STUDIES, 2023, 24 (05) : 1663 - 1682
  • [38] Treatment with Immunosuppressive Therapy May Improve Depressive Symptoms in Patients with Inflammatory Bowel Disease
    Sara Horst
    Andrew Chao
    Michael Rosen
    Anne Nohl
    Caroline Duley
    Julianne H. Wagnon
    Dawn B. Beaulieu
    Warren Taylor
    Lawrence Gaines
    David A. Schwartz
    Digestive Diseases and Sciences, 2015, 60 : 465 - 470
  • [39] Mindfulness-Based Cognitive Therapy for Patients with Medically Unexplained Symptoms: A Randomized Controlled Trial
    van Ravesteijn, Hiske
    Lucassen, Peter
    Bor, Hans
    van Weel, Chris
    Speckens, Anne
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2013, 82 (05) : 299 - 310
  • [40] Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting
    Afzali, Anita
    Ogden, Kristine
    Friedman, Michael L.
    Chao, Jingdong
    Wang, Anthony
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) : 409 - 422